This is the second update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the public health risk associated with the current EVD outbreak in the DRC and its implications for EU/EEA citizens.
The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
This rapid risk assessment addresses the public health risk associated with the current Ebola virus disease outbreak in the Democratic Republic of the Congo and its implications for EU/EEA citizens. This is the first update of a rapid risk assessment originally produced on 9 August 2018.
On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.